Auth bypass in Bd Alaris Cc
CVE-2018-14786
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Vulnerability class: Broken Authentication
EPSS: 0.031 (86.2th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 9.4 (Critical). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H.
Affected products
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (VDB Entry, Third Party Advisory, vdb-entry, x_refsource_BID)
- ics-cert@hq.dhs.gov (x_refsource_CONFIRM, Vendor Advisory)
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2018-14786?
- CVE-2018-14786 is a critical-severity vulnerability in Bd Alaris Cc, classified under Improper Authentication. CVSS score: 9.4/10. Published 2018-08-23.
- How severe is CVE-2018-14786?
- Critical severity. CVSS v3 base score is 9.4 out of 10.